Anthem (ANTM) Hits New Lifetime High

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Anthem ( ANTM) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Anthem as such a stock due to the following factors:

  • ANTM has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $396.5 million.
  • ANTM has traded 15,557 shares today.
  • ANTM is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ANTM with the Ticky from Trade-Ideas. See the FREE profile for ANTM NOW at Trade-Ideas

More details on ANTM:

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial and Specialty Business, Government Business, and Other. The stock currently has a dividend yield of 1.6%. ANTM has a PE ratio of 16. Currently there are 8 analysts that rate Anthem a buy, no analysts rate it a sell, and 8 rate it a hold.

The average volume for Anthem has been 1.7 million shares per day over the past 30 days. Anthem has a market cap of $42.0 billion and is part of the health care sector and health services industry. The stock has a beta of 0.41 and a short float of 2.5% with 2.83 days to cover. Shares are up 26.4% year-to-date as of the close of trading on Tuesday.

If you liked this article you might like

Equifax's Future Could Go in One of Two Directions

Equifax's Massive Data Breach Focuses Attention on Symantec's LifeLock

Anthem to Scale Back Obamacare Offerings in Missouri

Healthcare Management Stocks Look Too Pricey for Activists

Biotech Movers: Jazz Shares Lower Amid Notes Offering